卡前列素氨丁三醇联合缩宫素治疗高危妊娠阴道分娩产后出血产妇的临床效果

doi:10.3969/j.issn.1671-7171.2024.08.019

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1163 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To investigate the clinical efficacy of combining carboprost tromethamine with oxytocin in the treatment of postpartum hemorrhage in high-risk pregnant women undergoing vaginal delivery. 【Methods】A retrospective analysis was conducted on the clinical data of 82 high-risk pregnant women with postpartum hemorrhage who underwent vaginal delivery in our hospital from February 2019 to February 2023. They were divided into the control group (treated with oxytocin) and the observation group (treated with carboprost tromethamine combined with oxytocin) according to different treatment methods, with 41 cases in each group. Two groups were compared in terms of general information, clinical efficacy, incidence of postpartum adverse reactions, bleeding volume at 1, 3, and 9 hours postpartum, as well as peak systolic velocity (PSV) and pulsatility index (PI) of uterine arteries before treatment, 15 minutes after treatment, and 1 hour after treatment.【Results】The total effective rate of the observation group was higher than that of the control group (P<0.05). The amount of bleeding in the observation group at 3 and 9 hours postpartum was lower than that in the control group at 3 and 9 hours postpartum (P<0.05). Compared with before treatment, both groups showed a decrease in PSV and PI at 15 minutes and 1 hour after treatment (P<0.05); The PSV of the observation group was higher than that of the control group at 15 minutes and 1 hour after treatment, and the PI was lower than that of the control group (P<0.05). There was no statistically significant difference in the total incidence of adverse reactions between the two groups (P>0.05). 【Conclusion】The use of oxytocin combined with carboprost tromethamine in the treatment of postpartum hemorrhage in high-risk pregnant women undergoing vaginal delivery is effective, can improve maternal hemodynamic indicators, and has high safety. It is worthy of clinical promotion and application.

Key words： Natural Childbirth Postpartum Hemorrhage/DT Tromethamine Carboprost Oxytocin

Received: 17 January 2024

PACS:

R714.461

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	NIU Huihui
	HAN Lipin

Cite this article:

NIU Huihui,HAN Lipin. Clinical Efficacy of Carboprost Tromethamine Combined with Oxytocin in the Treatment of Postpartum Hemorrhage in high-risk Pregnant Women Undergoing Vaginal Delivery[J]. JOURNAL OF CLINICAL RESEARCH, 2024, 41(8): 1185-1187.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2024.08.019 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2024/V41/I8/1185

[1] 伊同英,李静,张正玲,等. 卡贝缩宫素联合缩宫素预防高危妊娠阴道分娩产后出血的临床分析[J].甘肃医药,2020,39(5):403-405.
[2] 蒋双玲. 探讨卡贝缩宫素联合缩宫素预防高危妊娠阴道分娩产后出血的临床效果[J].中国保健营养,2023,33(1):46-48.
[3] 傅金花. 系统性护理模式对高危妊娠孕产妇阴道分娩产后出血的影响研究[J].中国医学创新,2022,19(6):99-103.
[4] 王迪,许晓琴. 氨甲环酸联合马来酸麦角新碱治疗初产妇产后出血的临床疗效[J].医学临床研究,2023,40(9):1299-1302.
[5] 岳晓燕,李艳,薛梦洋. 系统性护理对高危妊娠孕产妇阴道分娩产后出血的护理研究[J].健康大视野,2021,5(1):170.
[6] 袁静,向艳,杨艳琴. 系统性护理对高危妊娠孕产妇阴道分娩产后出血的护理研究[J].饮食保健,2021,6(19):214.
[7] 王井菊. 系统性护理对高危妊娠孕产妇阴道分娩产后出血的护理观察[J].健康之友,2023,9(11):184-186.
[8] 李秀云. 米索前列醇联合缩宫素与单用缩宫素预防产后出血的疗效比较[J].临床医药实践,2010,19(4):277-278.
[9] 陈比娟,黄玉英,钟柳波. Foley's尿管联合缩宫素及间苯三酚用于足月高危妊娠引产的临床效果观察[J].现代诊断与治疗,2016,27(12):2245-2246.
[10] 黄睿,颜涛玲,傅益萍. 麦角新碱联合卡前列素氨丁三醇用于预防具有高危产后出血因素产妇的临床效果及对凝血功能、子宫复旧的影响[J].吉林医学,2022,43(1):222-224.
[11] 罗志平,石珍珍. COOK宫颈球囊联合催产素在高危孕妇引产中的应用及对妊娠结局的影响[J].中国妇幼保健,2018,33(4):811-813.
[12] 郭卫,杨雪. 马来酸麦角新碱联合卡贝缩宫素治疗瘢痕子宫妊娠剖宫产术后出血产妇的临床效果及对凝血指标的影响[J].医学临床研究,2023,40(4):609-611.
[13] 杨碧玉. 米索前列醇联合益母草注射液与单纯使用益母草预防产后出血疗效比较[J].中国卫生产业,2019,8(20):13-14.
[14] 司徒翠瑶. 卡前列素氨丁三醇联合缩宫素治疗高危妊娠阴道分娩产后出血的临床疗效及其对血流动力学的影响[J].临床合理用药杂志,2021,14(24):151-153.
[15] 刘俊华. 探究缩宫素联合卡前列素氨丁三醇治疗高危妊娠阴道分娩产后出血的临床疗效[J].大健康,2022,6(20):124.

[1]	. [J]. JOURNAL OF CLINICAL RESEARCH, 2024, 41(8): 1255-1257.